A publishing agreement has been reached between Wolters Kluwer, and the American Society of Nephrology (ASN). The agreement began in January 2023 and will cover three medical specialty journals published by ASN: Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, and Kidney360.
As part of Wolters Kluwer’s strategy to expand ASN’s journal readership globally, the company will make use of the Ovid® medical research platform, among other channels, in addition to digital channels to reach members and practitioners. ASN members will also receive special discounts on Wolters Kluwer nephrology products when they publish in their journals.
Susan E. Quaggin, ASN President said,
“Through our collaboration with Wolters Kluwer, we are reaffirming our commitment to sharing the highest-quality and most exciting peer-reviewed scientific findings in our leading nephrology publications. This new relationship will help further our vision of a world without kidney diseases by sharing new knowledge with health professionals and scientists, thereby advancing research and innovation.”
Jennifer Brogan, Vice President, Global Journal Publishing and Society Solutions of Health Learning, Research, and Practice, Wolters Kluwer, commented,
“We are delighted to welcome ASN to Wolters Kluwer—they are the leading source for innovation and research in the field of nephrology.”
Wolters Kluwer, Health is a leading global provider of information and point-of-care solutions to the healthcare industry. The Wolters Kluwer Group is a global provider of professional information, software solutions, and services to healthcare professionals, accountants, lawyers, investors, auditors, risk managers, and compliance officers.
American Society of Nephrology has over 20,000 professionals working in 132 countries, and it represents kidney disease patients and their families. Through ASN’s educational programs for health professionals and scientists, advances in research and innovation, and communication of new information, ASN has led the fight to prevent, treat, and cure kidney disease throughout the globe since 1966.